Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2017
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Array Biopharma (ARRY) Misses Q1 EPS by 4c, Sales Beat
November 1, 2016 8:02 AM EDTArray Biopharma (NASDAQ: ARRY) reported Q1 EPS of ($0.20), $0.04 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $39.3 million versus the consensus estimate of $32.47 million.
"We were pleased to report that COLUMBUS met its primary endpoint and demonstrated a... More

